First cancer centers begin using initial release of Elekta’s MOSAIQ 3 series
ATLANTA, February 24, 2021 – Elekta (EKTA-B.ST) announced today that several cancer centers are the early adopters of the company’s first release in the MOSAIQ[®] 3* series. Featuring increased automation and simplified user interfaces, MOSAIQ 3 is designed to significantly reduce workflow complexity and enhance overall efficiency, accuracy, consistency and performance. MOSAIQ 3 received US 510(k) clearance in December 2020. "This new version of MOSAIQ makes the software more user-friendly through a more intuitive interface, while guiding customers through the workflow to improve the